Skip to main content
SpringerLink
Log in

The haemophilia drug market

  • From the Analyst's Couch
  • Published:

From Nature Reviews Drug Discovery

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1: Current sales and 2027 market forecast for the haemophilia market.

Author information

Authors and Affiliations

  1. Decision Resources Group, London, UK

    Kerri Brown & Graeme Green

Authors
  1. Kerri Brown
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Graeme Green
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Graeme Green.

Related links

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Brown, K., Green, G. The haemophilia drug market. Nat Rev Drug Discov 17, 541–542 (2018). https://doi.org/10.1038/nrd.2018.54

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd.2018.54

  • Springer Nature Limited

Search

Navigation